SEC Form 4 · accession 0001645627-18-000067
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President
Period of report
Oct 17, 2018
Accepted (ET)
Oct 23, 2018 · 2:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 17, 2018 | P | 1,000 | $0.0444 | A | 26,065,498 | D | |
| Common Stock | Oct 17, 2018 | P | 1,000 | $0.0437 | A | 26,066,498 | D | |
| Common Stock | Oct 17, 2018 | P | 1,000 | $0.043 | A | 26,067,498 | D | |
| Common Stock | Oct 17, 2018 | P | 1,000 | $0.0419 | A | 26,068,498 | D | |
| Common Stock | Oct 17, 2018 | P | 1,000 | $0.0427 | A | 26,069,498 | D | |
| Common Stock | Oct 17, 2018 | P | 1,000 | $0.0428 | A | 26,070,498 | D | |
| Common Stock | Oct 19, 2018 | P | 2,000 | $0.0415 | A | 26,072,498 | D | |
| Common Stock | Oct 19, 2018 | P | 1,000 | $0.0415 | A | 26,073,498 | D | |
| Common Stock | Oct 19, 2018 | P | 2,000 | $0.043 | A | 26,075,498 | D | |
| Common Stock | Oct 19, 2018 | P | 2,000 | $0.0423 | A | 26,077,498 | D | |
| Common Stock | Oct 19, 2018 | P | 2,000 | $0.0425 | A | 26,079,498 | D | |
| Common Stock | Oct 19, 2018 | P | 1,000 | $0.0423 | A | 26,080,498 | D | |
| Common Stock | Oct 22, 2018 | P | 2,000 | $0.0435 | A | 26,082,498 | D |
Table II — derivative securities
No Table II lines on this filing.